T/CACM 1656-2025 Active Group standards

T/CACM 1656-2025 Guidelines for the Integrated Diagnosis and Treatment of Hashimoto's Thyroiditis by Traditional Chinese Medicine and Western Medicine

T/CACM 1656-2025

Publish Date: 2025-05-26 Implement Date: 2025-05-26 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CACM 1656-2025
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2025-05-26
Implement Date: 2025-05-26

Scope

Main technical content: This document defines the terminology of Hashimoto's thyroiditis in adults, provides diagnostic criteria and treatment plans combining traditional Chinese medicine (TCM) and Western medicine. This document is applicable to all medical institutions conducting integrated diagnosis and treatment of Hashimoto's thyroiditis, and is intended for TCM practitioners, integrated TCM and Western medicine practitioners, and Western medicine clinicians. This document is not applicable to patients during pregnancy and lactation. Note 1: Clinicians should use the recommended prescriptions and dosages in this document in accordance with the provisions of the Pharmacopoeia of the People's Republic of China (2020), clinical practice, and medication experience, and pay attention to the processing methods of special medicines. Note 2: The abbreviation table of this document is shown in Appendix A, and the summary quick recommendation table is shown in Appendix B.

Development Information

Related Standards

Contact Us